HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chantal Mathieu Selected Research

otelixizumab

1/2021A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes.
11/2011Otelixizumab in the treatment of type 1 diabetes mellitus.
11/2010Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes.
6/2005Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chantal Mathieu Research Topics

Disease

126Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2022 - 08/2002
56Type 2 Diabetes Mellitus (MODY)
07/2022 - 12/2004
35Hypoglycemia (Reactive Hypoglycemia)
01/2022 - 11/2006
27Neoplasms (Cancer)
07/2022 - 12/2002
27Inflammation (Inflammations)
01/2020 - 01/2002
22Autoimmune Diseases (Autoimmune Disease)
12/2021 - 04/2002
19Body Weight (Weight, Body)
12/2021 - 06/2005
19Vitamin D Deficiency
02/2019 - 01/2008
17Hyperglycemia
07/2022 - 02/2006
14Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
01/2022 - 03/2016
13Infections
03/2022 - 06/2007
13Insulin Resistance
01/2021 - 09/2004
12Cardiovascular Diseases (Cardiovascular Disease)
07/2022 - 04/2009
12Weight Loss (Weight Reduction)
10/2020 - 12/2003
11Gestational Diabetes (Gestational Diabetes Mellitus)
03/2022 - 03/2003
9Chronic Renal Insufficiency
07/2022 - 09/2010
9Chronic Obstructive Pulmonary Disease (COPD)
03/2022 - 04/2009
8Heart Failure
07/2022 - 03/2017
7Glucose Intolerance
10/2021 - 01/2008
7Obesity
01/2021 - 01/2012
6Disease Progression
01/2022 - 08/2006
6Weight Gain
01/2021 - 09/2009
5Ketosis
12/2021 - 06/2002
5Hypoxia (Hypoxemia)
04/2018 - 02/2015
4Diabetes Mellitus
12/2021 - 08/2005
4Gestational Weight Gain
03/2021 - 01/2016
4Diabetes Complications
01/2018 - 04/2002
4Endometriosis
09/2011 - 06/2006
4Asthma (Bronchial Asthma)
08/2008 - 01/2003
3Pneumonia (Pneumonitis)
03/2022 - 01/2019
3Overweight
03/2021 - 01/2014
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 10/2008
3Albuminuria
10/2020 - 07/2013
3Critical Illness (Critically Ill)
03/2020 - 12/2003

Drug/Important Bio-Agent (IBA)

83Insulin (Novolin)FDA Link
11/2022 - 06/2002
72Glucose (Dextrose)FDA LinkGeneric
07/2022 - 12/2002
51Vitamin DFDA LinkGeneric
03/2022 - 01/2003
27CytokinesIBA
02/2019 - 02/2003
221,25-dihydroxyvitamin DIBA
03/2020 - 04/2002
15Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2002
15dapagliflozinIBA
01/2021 - 11/2015
14Metformin (Glucophage)FDA LinkGeneric
07/2022 - 01/2008
13Calcitriol Receptors (Calcitriol Receptor)IBA
01/2017 - 01/2003
11Biomarkers (Surrogate Marker)IBA
05/2022 - 03/2008
10Sodium-Glucose Transport ProteinsIBA
05/2022 - 03/2016
10AutoantibodiesIBA
03/2022 - 10/2009
10Pharmaceutical PreparationsIBA
10/2020 - 05/2005
10AntigensIBA
01/2017 - 02/2003
9Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022 - 03/2017
9AutoantigensIBA
11/2018 - 02/2003
825-hydroxyvitamin DIBA
03/2020 - 04/2009
7Glucagon-Like Peptide-1 Receptor AgonistsIBA
07/2022 - 05/2011
7SodiumIBA
07/2022 - 11/2015
7Blood Glucose (Blood Sugar)IBA
01/2021 - 04/2006
7hydroxide ionIBA
03/2020 - 02/2003
7Hypoglycemic Agents (Hypoglycemics)IBA
01/2020 - 10/2006
7Interleukin-6 (Interleukin 6)IBA
02/2019 - 06/2006
7Messenger RNA (mRNA)IBA
02/2019 - 01/2002
7Calcitriol (Calcijex)FDA LinkGeneric
02/2015 - 08/2002
6Insulin Glargine (Lantus)FDA Link
01/2021 - 03/2011
6Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
06/2019 - 04/2012
6CalciumIBA
11/2016 - 01/2011
5InsulinsIBA
12/2021 - 12/2012
5EnzymesIBA
01/2021 - 10/2008
5Glucagon-Like Peptide 1 (GLP 1)IBA
01/2020 - 10/2012
5saxagliptinFDA Link
01/2019 - 11/2015
525-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
01/2017 - 10/2008
5Hormones (Hormone)IBA
01/2017 - 04/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2015 - 06/2006
5C-PeptideIBA
01/2013 - 06/2002
5AllergensIBA
08/2008 - 01/2002
4Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
12/2021 - 11/2006
4LiraglutideFDA Link
12/2021 - 10/2016
4Insulin Aspart (NovoLog)FDA Link
12/2021 - 01/2017
4AntibodiesIBA
01/2021 - 11/2011
4LipidsIBA
01/2021 - 01/2008
4VildagliptinIBA
01/2021 - 01/2008
4otelixizumabIBA
01/2021 - 06/2005
4Tacrolimus (Prograf)FDA LinkGeneric
10/2020 - 11/2006
4SmokeIBA
01/2019 - 09/2015
4Exenatide (Byetta)FDA Link
12/2013 - 11/2012
3Cholecalciferol (Vitamin D3)FDA Link
03/2022 - 08/2002
3Endoplasmic Reticulum Chaperone BiPIBA
12/2021 - 02/2015
3EpitopesIBA
12/2021 - 11/2018
3Triglycerides (Triacylglycerol)IBA
03/2021 - 03/2019
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 01/2012
3Peptides (Polypeptides)IBA
01/2021 - 11/2003
3Mycophenolic Acid (Cellcept)FDA LinkGeneric
10/2020 - 11/2006
3LDL CholesterolIBA
11/2019 - 11/2015
3Antimicrobial PeptidesIBA
02/2019 - 12/2014
3Muramidase (Lysozyme)IBA
02/2019 - 02/2003
3Adenosine Triphosphate (ATP)IBA
04/2018 - 03/2012

Therapy/Procedure

54Therapeutics
01/2022 - 12/2003
25Glycemic Control
01/2021 - 04/2006
10Injections
01/2019 - 01/2002
8Transplantation
10/2020 - 04/2002
6Islets of Langerhans Transplantation
01/2018 - 02/2006
4Bariatric Surgery
10/2018 - 01/2012
3Kidney Transplantation
01/2022 - 12/2002
3Cesarean Section (Caesarean Section)
01/2021 - 06/2019